P. Fabrigli

439 total citations
18 papers, 274 citations indexed

About

P. Fabrigli is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology. According to data from OpenAlex, P. Fabrigli has authored 18 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 11 papers in Management of Technology and Innovation and 8 papers in Hematology. Recurrent topics in P. Fabrigli's work include Blood transfusion and management (14 papers), Blood donation and transfusion practices (11 papers) and Blood groups and transfusion (6 papers). P. Fabrigli is often cited by papers focused on Blood transfusion and management (14 papers), Blood donation and transfusion practices (11 papers) and Blood groups and transfusion (6 papers). P. Fabrigli collaborates with scholars based in France, Belgium and United States. P. Fabrigli's co-authors include Olivier Garraud, Patricia Chavarin, Fabrice Cognasse, Sophie Acquart, Bernard Lamy, Yves Ozier, P. Renaudier, Jean‐Yves Muller, Danielle Rebibo and Sandrine Lafarge and has published in prestigious journals such as Blood, Transfusion and Vox Sanguinis.

In The Last Decade

P. Fabrigli

16 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Fabrigli France	5	161	143	70	70	48	18	274
Sarah K. Harm United States	10	163 1.0×	141 1.0×	71 1.0×	91 1.3×	13 0.3×	23	296
Sandra K. Thoman United States	5	278 1.7×	328 2.3×	88 1.3×	117 1.7×	36 0.8×	6	489
M. Dean Elfath United States	10	347 2.2×	296 2.1×	43 0.6×	201 2.9×	17 0.4×	16	476
P. R. Sohmer United States	10	185 1.1×	135 0.9×	42 0.6×	57 0.8×	17 0.4×	15	397
Jaime Oblitas United States	8	154 1.0×	154 1.1×	11 0.2×	121 1.7×	29 0.6×	9	335
Robert A. DeSimone United States	9	52 0.3×	60 0.4×	32 0.5×	38 0.5×	14 0.3×	41	252
M. J. Dijkstra‐Tiekstra Netherlands	11	218 1.4×	173 1.2×	31 0.4×	108 1.5×	12 0.3×	23	361
Benjamin Rioux‐Massé Canada	6	65 0.4×	123 0.9×	28 0.4×	16 0.2×	84 1.8×	19	228
Carolina Bonet Bub Brazil	9	68 0.4×	129 0.9×	35 0.5×	26 0.4×	12 0.3×	37	203
P.Y. Le Pennec France	12	59 0.4×	224 1.6×	26 0.4×	60 0.9×	28 0.6×	32	315

Countries citing papers authored by P. Fabrigli

Since Specialization

Citations

This map shows the geographic impact of P. Fabrigli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Fabrigli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Fabrigli more than expected).

Fields of papers citing papers by P. Fabrigli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Fabrigli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Fabrigli. The network helps show where P. Fabrigli may publish in the future.

Co-authorship network of co-authors of P. Fabrigli

This figure shows the co-authorship network connecting the top 25 collaborators of P. Fabrigli. A scholar is included among the top collaborators of P. Fabrigli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Fabrigli. P. Fabrigli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chavarin, Patricia, et al.. (2015). Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐ HC l– UVA (Intercept ^™ ) over a 5‐year period of extensive delivery. Vox Sanguinis. 109(4). 414–416. 16 indexed citations

Garraud, Olivier, et al.. (2014). Les différents types de plasmas thérapeutiques sont-ils équivalents ?. Transfusion Clinique et Biologique. 21(1). 31–36. 2 indexed citations

Nguyen, Kim, Fabrice Cognasse, P. Fabrigli, et al.. (2013). Platelet concentrates for transfusion: Preparation, principle and safety criteria for optimal tolerance and reduction of hazards. Hématologie. 19(6). 371–382. 3 indexed citations

Fabrigli, P., et al.. (2013). Évaluation du réchauffement à cœur d’une poche de CGR à sa sortie de la banque de sang. Transfusion Clinique et Biologique. 20(3). 333–333. 1 indexed citations

Chavarin, Patricia, et al.. (2013). A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten‐year survey period in France. Vox Sanguinis. 104(4). 337–341. 30 indexed citations

Garraud, Olivier, et al.. (2012). Novel Functions of Therapeutic Platelets as “Immune Cells”. Journal of Blood Disorders & Transfusion. 1(S1). 1 indexed citations

Ozier, Yves, Jean‐Yves Muller, Paul‐Michel Mertès, et al.. (2011). Transfusion‐related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion. 51(10). 2102–2110. 46 indexed citations

Deméocq, F, et al.. (2011). Pratiques transfusionnelles en pédiatrie : étude rétrospective monocentrique. Archives de Pédiatrie. 18(11). 1154–1161.

Chavarin, Patricia, et al.. (2011). Inactivation/réduction des pathogènes des concentrés de plaquettes : conséquences sur l’organisation de la transfusion plaquettaire. Transfusion Clinique et Biologique. 18(4). 472–477. 1 indexed citations

10.

Ozier, Yves, P. Renaudier, C. Caldani, et al.. (2010). Œdèmes pulmonaires transfusionnels : classification des cas notifiés en hémovigilance. Transfusion Clinique et Biologique. 17(5-6). 284–290. 4 indexed citations

11.

Fabrigli, P., Patricia Chavarin, Olivier Tournilhac, et al.. (2010). Analyse d’un incident bactérien grave transmis par transfusion d’un concentré plaquettaire. Transfusion Clinique et Biologique. 17(1). 9–13. 3 indexed citations

12.

Fabrigli, P., et al.. (2009). Expérience de régionalisation du conseil transfusionnel. Transfusion Clinique et Biologique. 16(1). 4–11. 1 indexed citations

13.

Fabrigli, P., et al.. (2009). Le conseil transfusionnel. Transfusion Clinique et Biologique. 16(2). 201–203.

14.

Fabrigli, P., et al.. (2008). Comment gérer une impasse transfusionnelle. Hématologie. 14(4). 291–297. 1 indexed citations

15.

Cognasse, Fabrice, Hind Hamzeh‐Cognasse, Sandrine Lafarge, et al.. (2008). Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study. Transfusion. 49(1). 91–98. 34 indexed citations

16.

Fabrigli, P., et al.. (2007). Évaluation d’un enseignement en transfusion sanguine proposé aux professionnels des établissements de santé. Transfusion Clinique et Biologique. 14(4). 420–432. 4 indexed citations

17.

Cazenave, Jean‐Pierre, M. Lambermont, Olivier Garraud, et al.. (2007). An Active Hemovigilance Program Characterizing the Safety Profile of 7,437 Platelet Transfusions Prepared with Photochemical Treatment (INTERCEPT™).. Blood. 110(11). 2894–2894. 1 indexed citations

18.

Cognasse, Fabrice, Patricia Chavarin, Sophie Acquart, et al.. (2006). Release of potential immunomodulatory factors during platelet storage. Transfusion. 46(7). 1184–1189. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact